Now Reading
Alkermes’ Katie Joyce To Speak at Women in Bio 2023
Alkermes’ Katie Joyce To Speak at Women in Bio 2023
Published 04-25-23
Submitted by Alkermes
Last week, Katie Joyce, VP of Corporate Affairs, participated in a panel discussion at this year's Women in Bio (WIB) Management Track event featuring women leaders in life science. This year’s event gave attendees the opportunity to connect with industry leaders and hear from a panel of executive women leaders discussing their career paths and individual experiences. To learn more about Women In Bio, visit their website: https://lnkd.in/ePbUHdj
Alkermes
Alkermes
Alkermes plc is a fully-integrated, global biopharmaceutical company developing innovative medicines in the fields of neuroscience and oncology. The company has a portfolio of proprietary commercial products focused on alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of product candidates in development for neurological disorders and cancer. Headquartered in Dublin, Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio. For more information, please visit Alkermes' website at www.alkermes.com.
More from Alkermes
